Genmab Strikes $8 Billion Deal for Cancer Treatment Maker MerusBMO analysts said in a note Monday they were “encouraged” that Genmab’s acquisition “could start to spur broader M&A in the sector.”Sign up for smart news, insights, and analysis on the biggest financial stories of the…This story appeared on thedailyupside.com , 2025-09-30 10:30:00.